Revascularization

In ACS, low-dose colchicine plus standard medical therapy for 12 months resulted in a lower, but statistically insignificant, rate of the composite primary outcome vs. placebo and standard therapy, a speaker reported.

Among patients who underwent PCI, an LDL level of 70 mg/dL or more was associated with elevated risk for subsequent CV events, according to data published in the Journal of the American College of Cardiology.

Among patients with peripheral artery disease who underwent revascularization, those with concomitant clinical evidence of CAD received greater absolute benefit of reduced risk for MACE from taking low-dose rivaroxaban than those with PAD without CAD.

Patients who aimed to lose weight with a partner after ACS or revascularization were more successful compared with those without a partner, researchers found.

Patients with stable ischemic heart disease and HF and/or left ventricular dysfunction experienced worse outcomes compared with patients who did not and may benefit more from invasive treatment strategies, researchers reported.

Among patients with acute MI, cardiogenic shock and multivessel CAD, multivessel PCI was associated with elevated risk for in-hospital complications and mortality compared with culprit-lesion-only PCI, researchers reported.

Patients who underwent IVUS-guided PCI had more comorbidities but experienced less mortality, MI and repeat revascularization during the follow-up period than patients who underwent PCI without IVUS, researchers reported.

Optimal techniques for stenting complex coronary bifurcation lesions.

Icosapent ethyl demonstrated a very early coronary revascularization benefit, according to findings from REDUCE-IT REVASC.

In patients with complex coronary bifurcation lesions, a systematic two-stent technique was associated with better outcomes compared with a provisional stenting approach, according to results of the DEFINITION II trial.